Targeting FANCD2 for therapy sensitization

Oncotarget. 2014 Jun 15;5(11):3426-7. doi: 10.18632/oncotarget.2070.
No abstract available

Publication types

  • Editorial

MeSH terms

  • DNA Damage
  • Fanconi Anemia / genetics
  • Fanconi Anemia / metabolism
  • Fanconi Anemia Complementation Group D2 Protein / genetics
  • Fanconi Anemia Complementation Group D2 Protein / metabolism*
  • Humans
  • Molecular Targeted Therapy
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Neoplasms / therapy*

Substances

  • Fanconi Anemia Complementation Group D2 Protein